A multicenter randomized phase III study to compare capecitabine alone or in combination with trastuzumab in patients with HER2 positive metastatic breast cancer and progression after previous treatment with trastuzumab.
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2014
At a glance
- Drugs Trastuzumab (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms TBP
- 31 Aug 2018 Biomarkers information updated
- 22 Feb 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 05 May 2010 Results of a cost-utility analysis based on this trial have been published in the Annals of Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History